16-89721732-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001113525.2(ZNF276):āc.92G>Cā(p.Arg31Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000215 in 1,347,172 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001113525.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF276 | NM_001113525.2 | c.92G>C | p.Arg31Pro | missense_variant | 1/11 | ENST00000443381.7 | NP_001106997.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF276 | ENST00000443381.7 | c.92G>C | p.Arg31Pro | missense_variant | 1/11 | 1 | NM_001113525.2 | ENSP00000415836 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152074Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000555 AC: 7AN: 12618Hom.: 0 AF XY: 0.000254 AC XY: 2AN XY: 7872
GnomAD4 exome AF: 0.0000100 AC: 12AN: 1194990Hom.: 0 Cov.: 31 AF XY: 0.00000861 AC XY: 5AN XY: 580598
GnomAD4 genome AF: 0.000112 AC: 17AN: 152182Hom.: 0 Cov.: 34 AF XY: 0.0000941 AC XY: 7AN XY: 74418
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2022 | The c.92G>C (p.R31P) alteration is located in exon 1 (coding exon 1) of the ZNF276 gene. This alteration results from a G to C substitution at nucleotide position 92, causing the arginine (R) at amino acid position 31 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at